1. Inicio
  2. Proyectos y Estudios
  3. A Phase 1b, Open-label, Parallel Group,Multiple-dose Study to Evaluate thePharmacokinetics, Safety, and Tolerability of Oral Decitabine and Cedazuridine (ASTX727) in Cancer Patients with Severe Renal Impairment and Cancer Patients with Normal Renal Function.

A Phase 1b, Open-label, Parallel Group,Multiple-dose Study to Evaluate thePharmacokinetics, Safety, and Tolerability of Oral Decitabine and Cedazuridine (ASTX727) in Cancer Patients with Severe Renal Impairment and Cancer Patients with Normal Renal Function.

Datos básicos

ENSAYO CLÍNICO ASTX727-17 2021-000947-35 HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Año de incio: 2022 Año de finalización: 2023

Documentos

  • No hay documentos

Participantes

Ver todos los Investigadores

Grupos

Financiadores - Promotores

ASTEX PHARMACEUTICALS INC

Compartir